C&L: NovaDel's Egberts quits CEO post

NovaDel CEO Jan Egberts, M.D., has resigned and Board Chairman Steven B. Ratoff will serve as interim president and CEO.

Ambrx has named Stephen Kaldor, Ph.D., as president and CEO.

Genstruct has appointed Christopher Z. Thomajan as its new CFO.

Acorda Therapeutics announced that COO Mary Fisher resigned to pursue other interests.

Peter Benton joins eTrials as COO on an interim basis.

Merrimack Pharmaceuticals has named William Slichenmyer, M.D. senior vice president and chief medical officer.

Micromet has promoted Carsten Reinhardt, M.D. from senior vice president of clinical development to senior vice president and chief medical officer.

PS Pharmaceuticals has named Andrew Rackear as associate general counsel, succeeding Val Antczak as general counsel.

Auriga Laboratories has appointed Lisa Tripodi vice president of trade relations.

Panacea Pharmaceuticals has named Steven A. Fuller, Ph.D. as vice president, product development, and Billie Jo Wood as director, clinical laboratory services.

Pacific Biometrics has named Richard J. Gordon, M.S., as its new vice president of business development and sales and marketing.

WuXi PharmaTech has named Dr. Deepak Hegde vice president of formulation development services.

Alnylam Pharmaceuticals has appointed Philip Chase to the position of vice president, legal; Eric Raichle to the position of vice president, human resources; and Jason Rhodes to the position of vice president, business development.

Alexza Pharmaceuticals has named Nasrat Hakim as vice president, quality.

Eastern Biotech & Life Sciences has named Pankaj Sohaney as a manager-marketing and business development for the Middle East region.

MonoGen has reported that Frank Leo has been appointed to its board of directors and Laurence Hootnick has resigned as a director.

Bioniche Life Sciences has named Dr. Lorne Babiuk as a member of its board of directors.

ProtoKinetix has elected Max Arella, PhD, to their board.

Phenomix Corporation has named James Harper and William Harris to the board.

Lorus Therapeutics has appointed Herbert Abramson to the board.

Auxilium Pharmaceuticals has named Dr. Dennis Langer as an independent director.

AerovectRx Corporation announced the founding members of its Scientific Advisory Board: Kenneth Brigham, M.D. (Chair)--Emory University School of Medicine; Robert Aris, M.D.--University of North Carolina School of Medicine; James J. Barry, Ph.D.--Creare, Inc.; Beth L. Laube, Ph.D.--Johns Hopkins University School of Medicine; Ralph Tripp, Ph.D.--University of Georgia; Gerald Smaldone, M.D., Ph.D.--State University of New York at Stony; Arlene Stecenko, M.D.--Emory University School of Medicine.

Suggested Articles

The readouts link the oral oxidative phosphorylation blocker imeglimin to near- and long-term improvements when given as a monotherapy and in combos.

Scientists at the University of Toronto, in collaboration with Agios, identified 182 genes that allow cancer cells to evade the immune system.

The FDA’s advisory committee chair has stepped down from reviewing the upcoming pandemic vaccines given her role in Moderna’s COVID-19 test.